본문 바로가기
KERD
논문KCI 등재

염화 제 2철의 적합치가 유도하는 쥐의 경동맥 혈전증 모델 : 은행 나무 추출물의 효과

Optimization of Ferric Chloride Induced Carotid Artery Thrombosis Model in a Rat: Effect of Ginkgo biloba Extracts

1

조회

0

다운로드

4

인용

0

참고문헌

키워드

주제분류기타자연과학

초록

.

Abstract

Animal models are important tools in thrombosis research and preclinical drug development. In recent studies, ferric chloride (FeCl3) has been widely used to induce arterial thrombosis in a variety of species. The purpose of this study was to find an optimal concentration of FeCl3 and validate this model suited better for thrombosis research. A small piece of filter paper, soaked in FeCl3 solution (10, 20 or 35%, v/v, in distilled water) was topically applied on the carotid artery of SD rats to measure the time to occlusion (TTO) and thrombus weight (TW) to ascertain 35%, as an optimal FeCl3 concentration (8.63 ± 0.92 min; p =0.000, 0.79 ± 0.03 mg/mm; p =0.000, respectively). To validate this experimental model, Ginkgo biloba special extract EGb761 (5, 10 or 30 mg/kg) as a reference agent administered by peritoneal route for 1h prior to the induction of thrombosis, showed significantly delayed TTO in a dose dependent manner (18.50 ± 2.17, 29.17 ± 1.83, and 38.00 ±1.79 min, respectively) and significantly reduced TW and repaired collagen fibre in the injured vessel compare to vehicle group. Our results provide a simple, reproducible and well controlled in vivo screening system to induce thrombosis in rats by the topical application of 35% FeCl3 to assess the efficacy of the new anti-thrombotic agents.

참고문헌 (30)

  1. Adzu B, "Neuropharmacological screening of Diospyrosmespiliformis in mice", J Ethnopharmacol, 83, pp.139~143 (2002)
  2. Belougne E, , Thromb Res, 82, pp.453~458 (1996)
  3. Hennan JK, "Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis", J Thromb Haemost, 6, pp.1558~1564 (2008)
  4. Hsiao G, "Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo", Eur J Pharmacol, 465, pp.281~287 (2003)
  5. Huang X, "Strategy for analysis and screening of bioactive compounds in traditional Chinese medicines", J Chromatogr B Analyt Technol Biomed Life Sci, 812, pp.71~84 (2004)
  6. Jeon WK, "The modified Je-Ho-Tang, Korean herbal medicine, inhibits whole-blood aggregation and platelet adhesion to collagen under flow", Thromb Res, 122, pp.804~809 (2008)
  7. Jeon WK, "Anti-platelet effects of bioactive compounds isolated from the bark of Rhus verniciflua Stokes", J Ethnopharmacol, 106, pp.62~69 (2006)
  8. Won Kyung Jeon, "A Trend of Yin-tonifying Formulas Compared with Yang-tonifying Formulas on Anti-platelet and Anti-thrombotic Activity", 대한한의학회지, 30(6), pp.1~8 (2009), 대한한의학회
  9. 전원경, "한약재 추출물에 대한 전혈응집억제 효능 검색", Applied Biological Chemistry, 50(4), pp.352~357 (2007), 한국응용생명화학회
  10. Seul-Ki Kim, "Effects of Modified Je-Ho-Tang on Ferric Chloride-induced Thrombosis in a Rat Model and of Peripheral Circulatory Disturbance in a Mouse Model", Applied Biological Chemistry, 53(6), pp.842~846 (2010), 한국응용생명화학회
  11. 김영대, "목초액의 혈소판 응집억제를 통한 혈행개선 작용에 관한 연구", 한국독성학회지, 20(2), pp.137~142 (2004), 한국독성학회
  12. Kim YW, "Evalution of thrombolytic effect of streptokinase-dextran conjugate in a rat model of arterial thrombosis", J Kor Pharm Sci, 29, pp.211~216 (1999)
  13. Konstantinides S, "Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice", Circulation, 103, pp.576~583 (2001)
  14. Kurz KD, "Rat model of arterial thrombosis induced by ferric chloride", Thromb Res, 60, pp.269~280 (1990)
  15. Leadley RJ Jr, "Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents", J Pharmacol Toxicol Methods, 43, pp.101~116 (2000)
  16. Lee CK, "Protein fraction extracted from the earthworm lumbricusrubellus activates proteinase activated recetor-2 and is effective on hemokinesis", J Pharm Soc Korea, 41, pp.247~254 (1997)
  17. Lee JH, "The effect of the long-term ginseng intakes on serum lipids profile and hemostatic factors in human", Korean J Nutrition, 28, pp.862~871 (1995)
  18. Packham MA, "Role of platelets in thrombosis and hemostasis", Can J Physiol Pharmacol, 72, pp.278~284 (1994)
  19. Ryu KH, "Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time", Thromb Res, 124, pp.328~334 (2009)
  20. Shah HD, "Glycoprotein IIb", IIIa receptor and its inhibition: A platelet-directed therapeutic strategy, 2004, pp.36, 133~139
  21. Umar A, "Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo", Thromb Res, 110, pp.135~140 (2003)
  22. Wang X, "Murine model of ferric chloride-induced vena cava thrombosis:evidence for effect of potato carboxypeptidase inhibitor", J Thromb Haemost, 4, pp.403~410 (2006)
  23. Wang X, "An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research", Thromb Res, 115, pp.95~100 (2005)
  24. Woollard KJ, "Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury", J Biol Chem, 284, pp.13110~13118 (2009)
  25. Xiang YZ, "Strategies for antiplatelet targets and agents", Thrombo Res, 123, pp.35~49 (2008)
  26. Bo Kyung Yoo,, "Efficacy of Aspirin on Improvement of Peripheral Blood Circulation in Mice", Applied Biological Chemistry, 52(1), pp.22~27 (2009), 한국응용생명화학회
  27. 윤여표, "녹차카텐킨류의 항혈전 효과", 한국식품위생안전성학회지, 11, pp.77~82 (1996)
  28. 전원경, "한약재의 전혈혈소판응집억제", 한국한의학연구원논문집, 9, pp.55~67 (2003)
  29. 전원경, "KIOM2003-080 처방에 대한 항혈전효능연구", 한국한의학연구원논문집, 12, pp.143~147 (2007)
  30. 전원경, "한약재 추출물에 대한 전혈응집억제 효능 검색", Applied Biological Chemistry, 50(4), pp.352~357 (2007), 한국응용생명화학회

관련 논문AI추천

이 간행물의 다른 논문 (10건)